Screener
Staar Surgical STAA Merger Costs
Merger Costs at other companies
Other financials
Where this comes from
Reported directly by Staar Surgical in its filing.
Tagged under the XBRL concept staa:MergerCosts.
The source filing: Staar Surgical’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000718937-26-000023
| Line item | Three Months Ended / April 3, 2026 | Three Months Ended / March 28, 2025 |
|---|---|---|
| General and administrative | 17,022 | 24,458 |
| Selling and marketing | 24,509 | 26,945 |
| Research and development | 9,925 | 11,339 |
| Merger transaction and related costs | 6,743 | — |
| Restructuring, impairment and related charges | 2,681 | 22,664 |
| Total selling, general and administrative expenses | 60,880 | 85,406 |
| Operating income (loss) | 7,979 | (57,401) |
| Other income (expense), net: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Staar Surgical's merger costs?
- Staar Surgical (STAA) reported merger costs of $6.74M in Q1 2026.
- What does merger costs mean?
- This metric represents the non-recurring expenses incurred during the pursuit, negotiation, or integration of business combinations and acquisitions. These costs typically include advisory fees, legal expenses, and integration-related professional services. Investors monitor this to distinguish between core operational performance and one-time expenditures related to inorganic growth strategies.
Ask your AI about Staar Surgical's merger costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude